Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eli Lilly And Co (LLY) vs Roundhill Magnificent Seven ETF (MAGS) Price & Performance

Eli Lilly And CoTrade
Roundhill Magnificent Seven ETFTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Roundhill Magnificent Seven ETF — how do they compare? Eli Lilly And Co trades at $1,173 (market cap $1.02T), while Roundhill Magnificent Seven ETF trades at $66.74. The key difference: Eli Lilly And Co pays a 0.6% dividend while Roundhill Magnificent Seven ETF pays none. Which is the better fit depends on your goals.

LLYMAGS
Market Cap
$1.02T
Sector
HealthSector/Thematic
52-Week High
$1.24K$70.94
52-Week Low
$625.65$55.39
Enterprise Value
$1.06T
Dividend Yield
0.6%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,175.15, down 0.33% on the day, with a bullish technical signal and strong fundamental momentum. Revenue surged to $65.18B in 2025, with net income reaching $20.64B, and the company has beaten earnings estimates for three consecutive quarters. Recent news includes a lawsuit from Novo Nordisk over weight-loss drug advertising, but analyst sentiment remains overwhelmingly positive with a $1,380 consensus price target.

Outlook is supported by robust earnings growth and high profitability margins, but risks include competitive pressures and elevated valuation multiples. The stock's current price is near key resistance at $1,174, with institutional buying activity indicating continued confidence in Lilly's growth trajectory in the pharmaceutical sector.

Roundhill Magnificent Seven ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY

About Roundhill Magnificent Seven ETF

MAGS is an ETF that provides concentrated exposure to the seven technology-focused mega-cap companies often referred to as the 'Magnificent Seven' (Alphabet, Amazon, Apple, Meta, Microsoft, NVIDIA, and Tesla). The fund is designed to capture the performance of these market-leading stocks, which have been the primary drivers of market returns. It offers a simple way for investors to invest solely in this select group of high-growth technology companies.

Read more on MAGS